CRST has over 25 years of experience in conducting first-in-human (FIH) and other early-phase clinical pharmacology studies in healthy volunteers and patients. We offer services for phase I–IV trials, tailored to our customers’ needs. Our experience and expertise allow us to offer cost-efficient and flexible services. We provide tailored service solutions, adapting to the customer’s requirements and priorities in the context of established regulatory, medical and scientific frameworks.
We provide our clients a full-service phase 1 trial package from study design to final report. Our experience and expertise allow us to offer cost-efficient and flexible services.
We have experience in multiple studies e.g. in the areas of CNS, cardiovascular and metabolic disorders, vaccines, gastroenterology and PET imaging.
CRST’s competent teams can help customers to achieve their goals with careful planning and conduct of clinical trials on health foods and medical devices.
Our clients (Biotech and Pharma companies and CROs) can utilize our two centrally located clinical research units in Finland to speed up subject recruitment and to ensure high data quality. Our clinical research units in Turku and Helsinki are easily accessible for over half of the Finnish population. Read more about our study subject recruitment.
CRST has most extensive experience of trials in CNS and cardiovascular and metabolic disorders as well as gastroenterology, but has also gained relevant experience in many other therapy areas by networking with experts at hospitals and private clinics.